ArticleJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG2026
Well-being in German patients with vitiligo in genital and visible areas - a pilot study.
Article in Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Well-being in German patients with vitiligo in genital and visible areas - a pilot study.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOnly a few studies exist on the psychosocial impact of vitiligo in German patients, in particular those affected in genital and visible body areas.
methodsThis monocentric pilot study aimed to assess well-being of adult patients with vitiligo and to compare sex, age, and clinical characteristics between patients with and without genital, facial and hand involvement. Well-being was assessed using the WHO-5 questionnaire and quality of life with the Dermatology Life Quality Index (DLQI). Furthermore, psychometric properties of the WHO-5 well-being index were tested.
resultsIn total, 110 patients (mean age ± SD: 47.5 ± 14.7 years; 54.5% female; 95.5% with non-segmental vitiligo) were included. The WHO-5 mean score was 13.3, with 46 patients (42.2%) having a score < 13, indicating reduced well-being. Sixteen patients (14.7%) had a WHO-5 score < 7, indicating a high probability of depression. No significant differences in WHO-5 or DLQI scores were found between patients with vs without genital, facial, and hand involvement. Psychometric properties were confirmed to be good.
conclusionsOur findings emphasize the psychosocial impact of vitiligo in German patients, as reflected by reduced well-being, and suggest the usefulness of the WHO-5 as a simple psychosocial screening tool for routine care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.